Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
MCLEAN, Va., Oct. 10, 2017 -- Gladstone Capital Corporation (NASDAQ:GLAD) (the “Company”) announced today that its board of directors declared the following monthly cash distributions for October, November and December 2017.
Cash Distributions:
Common Stock: $0.07 per share of common stock for each of October, November and December 2017, payable per the table below. The Company has paid 168 consecutive monthly cash distributions on its common stock. Prior to paying distributions on a monthly basis, the Company paid eight consecutive quarterly common stock cash distributions.
| Record Date | Payment Date | Cash Distribution | ||
| October 20 | October 31 | $0.07 | ||
| November 20 | November 30 | $0.07 | ||
| December 19 | December 29 | $0.07 | ||
| Total for the Quarter: | $0.21 | |||
Term Preferred Stock: $0.141667 per share of the Company’s 6.00% Series 2024 Term Preferred Stock (“Term Preferred Stock”) for the prorated period from and including the issuance date (September 27, 2017) to and including September 30, 2017, plus the full month of October 2017, and $0.125 per share for each of November and December 2017, payable per the table below. The Term Preferred Stock trades on the NASDAQ under the symbol “GLADN.”
| Record Date | Payment Date | Cash Distribution | ||
| October 20 | October 31 | $0.141667 | ||
| November 20 | November 30 | $0.125 | ||
| December 19 | December 29 | $0.125 | ||
| Total for the Quarter: | $0.391667 | |||
The Company offers a dividend reinvestment plan (the “DRIP”) to its common stockholders. For more information regarding the DRIP, please visit www.gladstonecapital.com.
Gladstone Capital Corporation is a publicly traded business development company that invests in debt and equity securities consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. Information on the business activities of all the Gladstone funds can be found at www.gladstonecompanies.com.
For Investor Relations inquiries related to any of the monthly dividend paying Gladstone funds, please visit www.gladstone.com.
For further information: Gladstone Capital Corporation, +1-703-287-5893
